LSLouisa P. Selvadurai

Louisa P. Selvadurai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Louisa P. Selvadurai has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Two-year decline in performance on the Cerebellar Cognitive Affective Syndrome Scale in spinocerebellar ataxias

    byĀ Louisa P. Selvadurai, Chiara Lo Giudice, Sarah Wallis, James Morgan, Kishore R. Kumar, David J. Szmulewicz, Ian H. Harding

    Background and objectives Cognitive deficits are observed in a subset of individuals with spinocerebellar ataxias (SCAs); however, there is limited research on the longitudinal trajectory of such deficits. We investigated longitudinal cognitive performance amongst individuals with SCAs relative to controls, and the relationship of change in cognitive performance with change in self-reported function. Methods Individuals with symptomatic SCA1, SCA2, SCA3, and SCA6 as well as unaffected controls were administered the Cerebellar Cognitive Affective Syndrome Scale (CCAS-S) at yearly intervals for up to two years. Participants with SCA self-reported day-to-day cognitive and motor function via annual completion of the Patient-Reported Outcome Measure of Ataxia. Results Significant two-year decline in CCAS-S performance was observed in individuals with SCA (n = 25). In a larger cohort of individuals who completed 1-year follow-up (n = 45 SCA), greater decline was observed among individuals with better baseline performance, and, at a trending level, those with milder motor ataxia severity. Greater one-year decline on the CCAS-S was significantly associated with greater decline in self-reported day-to-day cognitive function. In contrast, one-year CCAS-S change was not related to change in self-reported motor function. Conclusions The CCAS-S indexes functionally relevant cognitive change over time in SCAs, with this decline apparent in at least a subset of individuals with SCAs. Decline in cognitive performance may be particularly pronounced in early/mild disease stages. Our results motivate larger and longer-term studies of the CCAS-S in SCAs, including investigating cognitive change across the pre-symptomatic and symptomatic disease course, and identifying risk factors for cognitive decline, to inform appropriate clinical support.


  • Open Access

    Psychomotor and non-motor correlates of cognition in spinocerebellar ataxias Types 1, 2, 3, and 6

    byĀ Louisa P Selvadurai, Sheryl Gullia, James Morgan, Sarah Wallis, Kishore R Kumar, David J Szmulewicz, Ian H Harding

    There is growing evidence of cognitive deficits in spinocerebellar ataxias, with the Cerebellar Cognitive Affective Syndrome Scale (CCAS-S) an increasingly common measure of this dysfunction. There remain ongoing questions as to how Cerebellar Cognitive Affective Syndrome Scale performance relates to day-to-day cognitive function, non-motor and motor features of spinocerebellar ataxias and demographic factors. Via an online study, we evaluated Cerebellar Cognitive Affective Syndrome Scale performance amongst individuals with spinocerebellar ataxia Type 1 (n = 14), Type 2 (n = 16), Type 3 (n = 18), and Type 6 (n = 26) relative to demographically-matched control groups. Furthermore, amongst individuals with spinocerebellar ataxia, we examined associations between performance and (i) age and education, (ii) ataxia motor severity, (iii) psychomotor function measured by computerized finger tapping and reaction time tasks and (iv) self-rated cognition, depression, emotional regulation, psychosocial function and fatigue. Cerebellar Cognitive Affective Syndrome Scale performance was significantly reduced in spinocerebellar ataxia Types 2, 3, and 6 compared to controls, although substantial inter-individual variability in performance was observed in the spinocerebellar ataxia cohort (43.2%/24.3%/21.6%/10.8% met criteria for Definite, Probable, Possible, and No CCAS). Performance in individuals with spinocerebellar ataxias correlated significantly with self-reported ataxia motor severity, fine motor speed, psychomotor trial-by-trial variability, and one of two measures of day-to-day cognitive function. Significant correlations were not observed against age, education, age at disease onset, disease duration, psychomotor reaction time, depression, emotional regulation, psychosocial function, or fatigue. We present evidence that motor function and psychomotor variability are more important correlates of inter-individual variability in cognitive performance amongst people with spinocerebellar ataxia Types 1, 2, 3 and 6, compared to demographic factors, fatigue, or emotional function. Importantly, formalized cognitive testing using the Cerebellar Cognitive Affective Syndrome Scale correlates with self-reported cognitive functioning. This study highlights cognitive dysfunction as a functionally impactful feature of certain spinocerebellar ataxias, and motivates further investigation into the disease- and individual-specific profiles of cognitive impairment in this population.


  • Open Access

    The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias

    byĀ Louisa P. Selvadurai, Susan L. Perlman, Tetsuo Ashizawa, George R. Wilmot, Chiadi U. Onyike, Liana S. Rosenthal, Vikram G. Shakkottai, Henry L. Paulson, Sub H. Subramony, Khalaf O. Bushara, et al.

    The Cerebellar Cognitive Affective/Schmahmann Syndrome (CCAS) manifests as impaired executive control, linguistic processing, visual spatial function, and affect regulation. The CCAS has been described in the spinocerebellar ataxias (SCAs), but its prevalence is unknown. We analyzed results of the CCAS/Schmahmann Scale (CCAS-S), developed to detect and quantify CCAS, in two natural history studies of 309 individuals Symptomatic for SCA1, SCA2, SCA3, SCA6, SCA7, or SCA8, 26 individuals Pre-symptomatic for SCA1 or SCA3, and 37 Controls. We compared total raw scores, domain scores, and total fail scores between Symptomatic, Pre-symptomatic, and Control cohorts, and between SCA types. We calculated scale sensitivity and selectivity based on CCAS category designation among Symptomatic individuals and Controls, and correlated CCAS-S performance against age and education, and in Symptomatic patients, against genetic repeat length, onset age, disease duration, motor ataxia, depression, and fatigue. Definite CCAS was identified in 46% of the Symptomatic group. False positive rate among Controls was 5.4%. Symptomatic individuals had poorer global CCAS-S performance than Controls, accounting for age and education. The domains of semantic fluency, phonemic fluency, and category switching that tap executive function and linguistic processing consistently separated Symptomatic individuals from Controls. CCAS-S scores correlated most closely with motor ataxia. Controls were similar to Pre-symptomatic individuals whose nearness to symptom onset was unknown. The use of the CCAS-S identifies a high CCAS prevalence in a large cohort of SCA patients, underscoring the utility of the scale and the notion that the CCAS is the third cornerstone of clinical ataxiology.


  • Longitudinal structural brain changes in Friedreich ataxia depend on disease severity: the IMAGE-FRDA study

    byĀ Louisa P. Selvadurai, Nellie Georgiou-Karistianis, Rosita Shishegar, Cathlin Sheridan, Gary F. Egan, Martin B. Delatycki, Ian H. Harding, Louise A. Corben

    Background Friedreich ataxia is an inherited neurodegenerative disease, with cerebral and cerebellar pathology evident. Despite an increased understanding of its neuropathology, disease progression in this disease remains poorly understood. This study aimed to characterise longitudinal change in brain structure using a multi-modal approach across cerebral and cerebellar grey and white matter. Methods T1-weighted, diffusion-tensor, and magnetisation transfer magnetic resonance images were obtained from 28 individuals with Friedreich ataxia and 29 age- and gender-matched controls at two time-points, 2 years apart. Region-of-interest and exploratory between-group comparisons assessed changes in brain macrostructure (cerebellar lobule volume, cerebral cortical thickness/gyrification, brain white matter volume) and microstructure (white matter fractional anisotropy, mean/axial/radial diffusivity, magnetisation transfer ratio). Rates of change were correlated against change in neurological severity, Time 1 severity, and onset age. Results Individuals with Friedreich ataxia had a greater rate of white matter volume loss than controls in the superior cerebellar peduncles and right peri-thalamic/posterior cerebral regions, and greater reduction in left primary motor cortex gyrification. Greater cerebellar/brainstem white matter volume loss and right dorsal premotor gyrification loss was observed amongst individuals with less severe neurological symptoms at Time 1. Conversely, cerebral atrophy and changes in axial diffusivity were observed in individuals with more severe Time 1 symptoms. Progression in radial diffusivity was more pronounced amongst individuals with earlier disease onset. Greater right ventral premotor gyrification loss correlated with greater neurological progression. Conclusion Heterogeneity in Friedreich ataxia progression is observed at the neurobiological level, with evidence of earlier cerebellar and later cerebral degeneration.


  • Open Access

    Multiple mechanisms underpin cerebral and cerebellar white matter deficits in Friedreich ataxia: The IMAGE‐FRDA study

    byĀ Louisa P. Selvadurai, Louise A. Corben, Martin B. Delatycki, Elsdon Storey, Gary F. Egan, Nellie Georgiou‐Karistianis, Ian H. Harding

    Friedreich ataxia is a progressive neurodegenerative disorder with reported abnormalities in cerebellar, brainstem, and cerebral white matter. White matter structure can be measured using in vivo neuroimaging indices sensitive to different white matter features. For the first time, we examined the relative sensitivity and relationship between multiple white matter indices in Friedreich ataxia to more richly characterize disease expression and infer possible mechanisms underlying the observed white matter abnormalities. Diffusion‐tensor, magnetization transfer, and T1‐weighted structural images were acquired from 31 individuals with Friedreich ataxia and 36 controls. Six white matter indices were extracted: fractional anisotropy, diffusivity (mean, axial, radial), magnetization transfer ratio (microstructure), and volume (macrostructure). For each index, whole‐brain voxel‐wise between‐group comparisons and correlations with disease severity, onset age, and gene triplet‐repeat length were undertaken. Correlations between pairs of indices were assessed in the Friedreich ataxia cohort. Spatial similarities in the voxel‐level pattern of between‐group differences across the indices were also assessed. Microstructural abnormalities were maximal in cerebellar and brainstem regions, but evident throughout the brain, while macroscopic abnormalities were restricted to the brainstem. Poorer microstructure and reduced macrostructural volume correlated with greater disease severity and earlier onset, particularly in peri‐dentate nuclei and brainstem regions. Microstructural and macrostructural abnormalities were largely independent. Reduced fractional anisotropy was most strongly associated with axial diffusivity in cerebral tracts, and magnetization transfer in cerebellar tracts. Multiple mechanisms likely underpin white matter abnormalities in Friedreich ataxia, with differential impacts in cerebellar and cerebral pathways.


  • Cerebral abnormalities in Friedreich ataxia: A review

    byĀ Louisa P. Selvadurai, Ian H. Harding, Louise A. Corben, Nellie Georgiou-Karistianis


  • Cerebral and cerebellar grey matter atrophy in Friedreich ataxia: the IMAGE-FRDA study

    byĀ Louisa P. Selvadurai, Ian H. Harding, Louise A. Corben, Monique R. Stagnitti, Elsdon Storey, Gary F. Egan, Martin B. Delatycki, Nellie Georgiou-Karistianis

    Friedreich ataxia (FRDA) is traditionally associated with neuropathology in the cerebellar dentate nucleus and spinal cord. Growing evidence also suggests involvement of the cerebral and cerebellar cortices, although reports of structural abnormalities remain mixed. This study assessed the structural integrity of cortical grey matter in FRDA, focussing on regions in which pathology may underlie the motor deficits characteristic of this disorder. T1-weighted anatomical magnetic resonance imaging scans were acquired from 31 individuals with FRDA and 37 healthy controls. Cortical thickness (FreeSurfer) and cortical volume (SPM-VBM) were measured in cerebral motor regions-of-interest (primary motor, dorsal and ventral premotor, and supplementary motor areas) alongside unconstrained exploratory analyses of the cerebral and cerebellar cortices. Correlations were assessed between cortical thickness/volume measures and each of disease severity, length of the causative genetic triplet-repeat expansion, and finger-tapping behavioural measures. Individuals with FRDA had significantly reduced cortical thickness, relative to controls, in the premotor and supplementary motor areas. Reduced cortical thickness and/or volume were also observed in the cuneus and precuneus, posterior aspects of the medial and lateral prefrontal cortices, insula, temporal poles, and cerebellar lobules V, VI, and VII. Measures of clinical severity, genetic abnormality, and motor dysfunction correlated with volume loss in the lateral cerebellar hemispheres. These results suggest that atrophy preferentially affects premotor relative to primary areas of the cortical motor system, and also extends to a range of non-motor brain regions. Furthermore, cortical thickness and cortical volume findings were largely divergent, suggesting that each is sensitive to different aspects of neuropathology in FRDA. Overall, this study supports a disease model involving neural aberrations within the cerebral and cerebellar cortices, beyond those traditionally associated with this disorder.


  • Psychometric assessment of the Cardiac Depression Scale Short Form in cardiac outpatients

    byĀ David L Hare, Louisa P Selvadurai, Jerry Q Wang, Ho Hin Yau, Madeline J Stone, Bhairavi Raman, Nibo Wu, William Y Shi, Samia R Toukhsati

    Background: Depression is common in patients with cardiovascular disease and is a risk marker for increased mortality. The valid and reliable detection of depression is fundamental to the appropriate management of these patients. Aim: The aim of this study was to evaluate the psychometric characteristics of the Cardiac Depression Scale Short Form 1 (DS-SF1) and the Cardiac Depression Scale Short Form 2 (DS-SF2) for screening cardiac outpatients in clinical settings. Methods: Adult cardiac outpatients attending a cardiovascular clinic completed the Cardiac Depression Scale (CDS), two versions of the DS-SF (DS-SF1 and DS-SF2) and the Physical Health Questionnaire 2 (PHQ2-Y/N) prior to their cardiac consultation. Results: Data from 326 patients (224 men; mean±SD age 66.25±14.39 years) were analysed. The DS-SF1 (mean score 16.28±5.70) had good construct validity with the CDS (r=0.77; pr=0.59; pr=0.84; pr=0.69; pConclusion: These findings confirm the excellent psychometric properties of the DS-SF2 as an ideal tool for screening depression in cardiac patients in clinical practice. The DS-SF2 should be regarded as the definitive version of the DS-SF.